JPMorgan cuts Alkami Technology price target to $13 from $14
ALKT•JPMorgan cut its price target for Alkami Technology to $13 from $14.
Related News
Biogen: Canaccord Genuity raises target price to $272 from $248
BIIB•
NAB expects RBA to raise cash rate 25 basis points to 4.85% in November
TLT•
Newmont target price cut to $132 from $135 by Canaccord Genuity
NEM•
Lincoln Electric Holdings target price raised to $340 from $320
LECO•
KLA Corporation: JPMorgan raises target price to $240 from $238
KLAC•